Bayer Animal Health presented its species portfolio of products and services at VIV Asia 2013 from 13 to 15 March 2013. As a pioneer of innovation, Bayer's expertise in the animal health market allows the company to truly understand and meet customers' needs. The innovative, technologically superior portfolio of Bayer exemplifies its commitment to providing species health solutions to its clients.

Attendees of the trade show discovered these products at an informative and interactive booth. Visitors also celebrated with Bayer its 150th anniversary of success through innovation and change. For over 90 years, Bayer has been a trusted partner in animal health, delivering solutions that meet the highest standards and clients' evolving needs. At the forefront of animal production, Bayer Animal Health constantly strives to enhance its products and services for swine, poultry and aquaculture production. Bayer applies global experience to local concerns to bring species health solutions to its customers.

Swine health – Focus on prevention and infectious diseases

Recent developments in the swine health market are met by Bayer Animal Health's vast portfolio of swine medications. Its products focus on prevention and treatment of infectious diseases as well as improving performance management. In 2013, Bayer Animal Health launched two vaccines in Asia: CSF-E2 marker (prevention of classic swine fever) and AR+rsPMT (prevention of swine progressive Atrophic Rhinitis) in Taiwan and Korea.

Baycox® for the control of coccidiosis and the anti-infective Baytril® are two essential pillars to Bayer's swine health portfolio. Around these key products available in most countries of the region Bayer built up local portfolios to best support producers with solutions along the entire production cycle.

In order to improve health and hygiene management on swine farms, Bayer presented at VIV Asia a special toolbox called 'Lab-on-Wheels'. The unique box offers different tests and diagnosis tools that can easily be used on the farm. This service is being used by Bayer representatives to detect the needs of the respective farm and to offer tailor-made solutions to the producer.

Poultry health – improving performance management with viable solutions

Bayer Animal Health strengthens its presence in Asia with its solutions for poultry health. Adding to its already extensive list of advanced nutraceuticals, Bayer enhances poultry health and performance with Baymix® Grobig BS, Latibon® Plus ME and Toxisorb® to name a few.

Baymix Grobig BS is a patented, non-antibiotic growth promoter that helps maintain gut health and integrity while controlling Clostridia and Salmonella infections. This advanced nutraceutical is a solution that is far superior in technology apart from being economically viable.

All these products are complemented by a comprehensive biosecurity portfolio encompassing a broad range of insecticides (QuickBayt®, Solfac®, Starycide®), disinfectants (Remedor®) and rodenticides (Racumin®, Rodilon®) that offer a remarkable tool to prevent the spread of disease in and around farms.

Aquaculture – comprehensive applications for fish and water quality

Bayer Animal Health is the only global pharmaceutical company that provides a broad aquaculture portfolio covering the entire production cycle in the main producing countries in Asia Pacific, China and Latin America. Bayer and its licensed partners started over the last decade to offer a growing number of cutting edge technology including water quality and fish farming. Besides the Bayer brands Hadaclean® A, and Coforta® A the company offers also several products from licensing partners such as PondDtox® PondSafe® from Novozymes Biologicals and Virasure® Aquatic from Fish Vet Group Ltd to complete the range.

To highlight their commitment to share and improve the aquaculture activities in the region, Bayer and its partners hosted in the context of the trade show a discussion forum of applied technology for Asian aquaculture environment for fish and shrimp aquaculture.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of €18.6 billion (2012), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,300 employees (as of 31 December 2012) and is represented in more than 100 countries. More information at www.healthcare.bayer.com.